Table of Contents: Oncotarget’s Volume 12, Issue #12
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
June 8, 2021
Author: Oncotarget
Behind the Study: PRAME Associated with Increased Metastatic Risk
Dr. Matthew G. Field discusses his 2016 study published by Oncotarget, entitled: “Epigenetic reprogramming and... read more
June 7, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #11
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
May 25, 2021
Behind the Study: Potential Therapeutic Target in Breast Cancer Cells
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study... read more
May 17, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #10
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
May 11, 2021
Behind the Study: Extending Survival in Glioma Models
Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more
May 10, 2021
Behind the Study: Symmetry and Symmetry Breaking in Cancer
Dr. Kenneth J. Pienta and Dr. J. James Frost describe their 2017 study published by... read more
May 3, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #9
Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more
April 27, 2021
Behind the Study: Prognostic Role of mir-24-3p in Breast Cancer
Researchers from NYU discuss their 2018 study published in Oncotarget, entitled, "Prognostic role of elevated... read more
April 26, 2021
Behind the Study: miRNA-185 Emerges as Regulator of KRAS
Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more
April 18, 2021